The recent challenges in global chains have highlighted the necessity of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes nations to potential vulnerabilities, including delivery delays, cost fluctuations, and even trade risks. Shifting towards domestic production of Ivermectin offers a multitude of advantag… Read More